iSAM Funds (UK)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$480K Sell
1,240
-1,452
-54% -$538K 0.34% 101
2026
Q1
$788K Buy
2,692
+1,141
+74% +$375K 0.39% 89
2025
Q4
$544K Sell
1,551
-2,471
-61% -$835K 0.2% 151
2025
Q3
$1.3M Sell
4,022
-1,240
-24% -$386K 0.27% 114
2025
Q2
$2.05M Buy
5,262
+2,972
+130% +$1.2M 0.45% 58
2025
Q1
$996K Buy
+2,290
New +$919K 0.49% 56
2024
Q4
Sell
-3,352
Closed -$1.74M 298
2024
Q3
$1.74M Buy
3,352
+2,119
+172% +$1.13M 0.99% 13
2024
Q2
$668K Buy
+1,233
New +$652K 0.5% 70
2023
Q3
Sell
-2,276
Closed -$1.01M 262
2023
Q2
$1.01M Buy
+2,276
New +$1.05M 0.9% 27

Other funds holding ELV

iSAM Funds (UK)'s ELV Position: Q2 2026 in Review

iSAM Funds (UK) reduced its Elevance Health (ELV) stake by 54% in Q2 2026, selling an estimated $538K and leaving 1,240 shares worth $480K. The position accounts for 0.34% of the portfolio, ranked #101.

iSAM Funds (UK) first reported a position in ELV in Q2 2023 and has held it in 9 quarters since. The position peaked at $2.05M in Q2 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • iSAM Funds (UK) held 1,240 shares of Elevance Health worth $480K as of Q2 2026.
  • iSAM Funds (UK) sold 1,452 Elevance Health shares in Q2 2026, an estimated $538K.
  • Elevance Health made up 0.34% of iSAM Funds (UK)'s portfolio in Q2 2026, its #101 holding.
  • iSAM Funds (UK) first reported a position in Elevance Health in Q2 2023 and has held it in 9 quarters since.
  • iSAM Funds (UK)'s Elevance Health position peaked at $2.05M in Q2 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on iSAM Funds (UK)'s 13F filing for Q2 2026, filed 12 Aug 2026.